Health TrialsbyHealthPanel

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

ConditionsToleranceUreteral Double-J StentUrinary Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patient over 18 years old

patient who need Ureteral Double-J Stenting

Disqualifiers

patient under 18 years old,

Iterative change,

understanding disorder,

inability to answer the questionnaire,

Trial design

Design model

Single group

Treatments tested in this trial

  • questionnary

    Other intervention

    On day 1 of an ureteral double J stenting, each participant will receive the first USSQ questionnaire, in the French validated version. This questionnaire will be completed at home, one week after the intervention and returned at the following consultation or hospitalization.

  • USSQ survey

    Other intervention

    if the stent is removed less than 6 months later, the second USSQ survey, in the French validated version will be given to the patient when removing the stent. This questionnaire will be completed at home one week after removal of the stent and return to the referent hospital. If the patient does not return the second questionnaire, our team may contact them by phone to complete it.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

tolerance score of Ureteral Double-J Stent

A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

Time frame
day 15
2

tolerance score of Ureteral Double-J Stent

A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

Time frame
3 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Centre Hospitalier d'Abbeville

Collaborator

Centre Hospitalier Intercommunal de Compiègne-Noyon

Collaborator

University Hospital, Caen

Collaborator

Source ClinicalTrials.gov
Apply now